Neuro Biomarker Platform
Total Trials
12
As Lead Sponsor
10
As Collaborator
2
Total Enrollment
2,261
NCT03733236
Safety and Effectiveness Evaluation of the ISS System in Treatment of Acute Ischemic Stroke
Phase: N/A
Role: Lead Sponsor
Start: Jul 6, 2006
Completion: Jan 31, 2009
NCT03767192
Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window (ImpACT-24A)
Start: Jan 31, 2009
Completion: Mar 31, 2012
NCT00826059
Implant for Augmentation of Cerebral Blood Flow Trial, Effectiveness and Safety in a 24 Hour Window
Start: Jun 30, 2011
Completion: Jun 30, 2018
NCT01874093
IMPACT- 24Bt Post Mech. Thrombectomy and/or rtPA TRIAL IMPlant Augmenting Cerebral Blood Flow 24 Hours From Stroke Onset
Phase: Phase 3
Start: May 31, 2013
NCT03396419
IMPACT- 24col Collateral Blood Flow Assessment Following SPG Stimulation in Acute Ischemic Stroke (ImpACT-24B Sub-Study)
Start: Sep 25, 2017
Completion: Jun 3, 2018
NCT03551093
THE IMPACT- 24M TRIAL (IMPlant Augmenting Cerebral Blood Flow in Mild Strokes Trial 24 Hours From Stroke Onset)
Start: Apr 2, 2018
Completion: Sep 11, 2018
NCT04014621
Augmenting Cerebral Blood Flow to Preserve the Penumbra Trial
Start: Oct 20, 2019
Completion: Apr 30, 2021
NCT04897464
Validation Study of a New Digital Treatment Test
Start: Jun 1, 2021
Completion: May 31, 2022
NCT05446922
Variability of Cerebral MRI Diffusion Parameters by Using a Patented Normalization Process vs no Use
Start: Sep 30, 2023
Completion: May 31, 2024
NCT05911919
Validation of a Prognostic Biomarker Using Brain Diffusion MRI in X-linked Adrenoleukodystrophy
Role: Collaborator
Completion: Sep 30, 2028
NCT06885060
Exploring Eye Vergence Markers ADHD) and ASD
Start: Feb 1, 2025
Completion: Jan 31, 2027
NCT06963879
Validation Study of a New Digital Diagnostic and Treatment Test Based on Interactive Video Games for Alzheimer's Disease
Start: May 1, 2025
Completion: Dec 31, 2025
Loading map...